BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 6824744)

  • 1. The enantiomer and the positional isomer of platelet-activating factor.
    Tence M; Coëffier E; Polonsky J; Benveniste J
    Biochim Biophys Acta; 1983 Feb; 755(3):526-30. PubMed ID: 6824744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of structural analogues of PAF-acether on platelet desensitization.
    Keraly CL; Coëffier E; Tencé M; Borrel MC; Benveniste J
    Br J Haematol; 1983 Mar; 53(3):513-21. PubMed ID: 6824590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle.
    Touqui L; Jacquemin C; Dumarey C; Vargaftig BB
    Biochim Biophys Acta; 1985 Jan; 833(1):111-8. PubMed ID: 3967037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets.
    Ostermann G; Till U; Thielmann K
    Thromb Res; 1984 Feb; 33(4):409-18. PubMed ID: 6710440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
    Keraly CL; Benveniste J
    Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthesis of paf-acether by E. coli K12].
    Thomas Y; Denizot Y; Dassa E; Boullet C; Benveniste J
    C R Acad Sci III; 1986; 303(17):699-702. PubMed ID: 3101984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation between inhibition of phospholipid methylation and production of PAF-acether by rabbit platelets.
    Touqui L; Chignard M; Jacquemin C; Wal F; Vargaftig BB
    Experientia; 1984 Apr; 40(4):374-7. PubMed ID: 6714369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues.
    Ostermann G; Kertscher HP; Till U
    Biomed Biochim Acta; 1985; 44(2):K17-23. PubMed ID: 4004829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine)-induced fibrinogen binding to platelets depends on metabolic energy.
    Kloprogge E; Hasselaar P; Akkerman JW
    Biochem J; 1986 Sep; 238(3):885-91. PubMed ID: 3800968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
    Grigoriadis G; Stewart AG
    Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.
    Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M
    Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
    Chignard M; Le Couedic JP; Vargaftig BB; Benveniste J
    Br J Haematol; 1980 Nov; 46(3):455-64. PubMed ID: 6778498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of human and rabbit blood platelets by synthetic structural analogs of platelet activating factor.
    Hadváry P; Baumgartner HR
    Thromb Res; 1983 Apr; 30(2):143-56. PubMed ID: 6868019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of PAF-acether and structural analogues on platelet activation and bronchoconstriction in guinea-pigs.
    Coëffier E; Borrel MC; Lefort J; Chignard M; Broquet C; Heymans F; Godfroid JJ; Vargaftig BB
    Eur J Pharmacol; 1986 Nov; 131(2-3):179-88. PubMed ID: 3816952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists.
    Hayashi H; Kudo I; Inoue K; Onozaki K; Tsushima S; Nomura H; Nojima S
    J Biochem; 1985 Jun; 97(6):1737-45. PubMed ID: 2993272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Alkyl-1,4-dihydropyridines derivatives as specific PAF-acether antagonists.
    Sunkel CE; de Casa-Juana MF; Santos L; Gómez MM; Villarroya M; González-Morales MA; Priego JG; Ortega MP
    J Med Chem; 1990 Dec; 33(12):3205-10. PubMed ID: 2175357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
    Herrmann DB; Ferber E; Munder PG
    Biochim Biophys Acta; 1986 Mar; 876(1):28-35. PubMed ID: 3947667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Ca2+ in regulating the catabolism of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in rabbit platelets.
    Touqui L; Shaw AM; Dumarey C; Jacquemin C; Vargaftig BB
    Biochem J; 1987 Jan; 241(2):555-60. PubMed ID: 3109377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-activating factor in normal rat uterus.
    Yasuda K; Satouchi K; Saito K
    Biochem Biophys Res Commun; 1986 Aug; 138(3):1231-6. PubMed ID: 3753495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.